Serum Institute of India has already produced around 50 million dosages of the Oxford-AstraZeneca COVID-19 vaccine 'Covishield' and plans to scale it up to 100 million by March next year even as it awaits approval for emergency use authorisation, a top company official said on Monday.
The company, which has launched the country's first indigenously developed pneumococcal vaccine PNEUMOSIL- for children, said the scaling up of the COVID-19 vaccine would also depend on the overall demand from the government.
In order to introduce an urgently needed vaccine against COVID-19 in India, Serum Institute of India (SII), the world's largest vaccine manufacturer, has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture Covishield. Why it can be a perfect fit for India? Here's an explainer.
T20 World Cup 2026: Speaking to India Today, former Pakistan Cricket Board chief Najam Sethi said Pakistan is now standing up to BCCI by announcing the boycott of their game against India. Sethi said the ICC is run by people in the BCCI and Pakistan are willing to let go off short-term financial gains to end the bullying of the global cricket body.
External Affairs Minister S Jaishankar met US Treasury Secretary Scott Bessent and held a discussion on advancing bilateral economic partnership and strategic cooperation,
Speaking at the World Government Summit in Dubai, Tony Chan, Former President of KAUST, said AI won’t replace scientists and engineers anytime soon, but it will transform how they work.
In an exclusive conversation with India Today, Hugo Boss CEO Daniel Grieder discusses the company's strategic focus on the Indian market.
